EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Delayed recognition of primary thyroid lymphoma with progressive thyroid enlargement and cardiopulmonary symptoms

Yara E Tovar, Ahmed G Elsayed, Manali Pragani, Paul T Romanoski, Ravleen Kaur, John Y Jun

JCEM Case Reports · 2026-10-16 · 4 (12)

DOI: 10.1210/jcemcr/luag339 ↗
AbstractBibliografische Angaben

Abstract

Abstract Primary thyroid lymphoma (PTL) is a rare thyroid malignancy that may present with respiratory symptoms overlapping with cardiopulmonary disease, contributing to delayed diagnosis. We report a 78-year-old woman with chronic lymphocytic thyroiditis, chronic obstructive pulmonary disease, heart failure, and prior lung cancer whose worsening dyspnea was repeatedly attributed to underlying cardiopulmonary conditions. She subsequently developed dysphonia and dysphagia with a rapidly enlarging thyroid mass requiring tracheostomy for airway protection. Prior computed tomography imaging obtained during multiple evaluations for cardiopulmonary symptoms incidentally demonstrated subtle thyroid enlargement with progressive interval growth on retrospective review. Core biopsy confirmed diffuse large B-cell lymphoma, and staging established stage IIIE disease. Given her age and comorbidities, a dose-reduced regimen of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone was initiated. Despite treatment, her condition deteriorated rapidly, and she died shortly thereafter. This case underscores how overlapping comorbidities can obscure PTL presentation until advanced airway compromise develops. In patients with persistent respiratory symptoms despite appropriate cardiopulmonary management, careful review of prior imaging is critical because subtle thyroid enlargement may otherwise be overlooked.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →